Skin & Tissue Repair · Research Blend
GLOW (Three-Peptide Blend)
A three-peptide research blend — GHK-Cu, BPC-157, and TB-500 — combining collagen, cytoprotective-repair, and cell-migration research pathways in one vial.
GLOW is a three-peptide research blend built around GHK-Cu (50mg) with BPC-157 and TB-500 at 10mg each — 70mg of total peptide content, the composition used consistently across the research-supply market. Each component carries its own substantial preclinical literature, and the blend exists so laboratories can study how their mechanisms interact in a single model system.
GLOW sits between our two other blends: it contains the complete BPC-157 + TB-500 pairing known as the “Wolverine” stack (covered on our BB research page) and adds GHK-Cu — the copper-binding tripeptide with one of the largest bodies of collagen and skin-remodeling research. KLOW extends the same three with KPV. The result spans three research axes: extracellular-matrix signaling, cytoprotective repair signaling, and cell migration with new-vessel formation. All supporting evidence is preclinical — cell and animal studies — and no human trials of the blend exist.
Research areas
Collagen & ECM Signaling
GHK-Cu — the largest share of the blend — is studied for stimulating collagen synthesis and modulating extracellular-matrix remodeling genes.
Cytoprotective Repair Signaling
BPC-157's rodent-model literature spans tendon, gut, muscle, and vascular repair — one half of the "Wolverine" pairing.
Cell Migration & Angiogenesis
TB-500's actin-sequestering activity and BPC-157's VEGFR2-pathway signaling are both investigated in vessel-formation and cell-motility models.
Skin & Wound-Healing Models
All three components have independent wound-model literature — collagen deposition, re-epithelialization, and repair signaling — which is why they are co-studied.
Recent research findings
- 2024Component research continued across all three peptides; multi-peptide blend designs became increasingly common in skin and tissue-repair study protocols.
- 2023Reviews consolidated GHK-Cu's gene-modulation and antioxidant data alongside continuing BPC-157 and Tβ4 repair-model work.
- 1988–2021Foundational literature for each component — collagen stimulation (GHK-Cu), cytoprotection (BPC-157), and actin regulation with wound closure (Tβ4) — established the mechanisms the blend is designed to co-study.
Published Research & Citations
The research summarized above is drawn from published, peer-reviewed studies. Explore the 6 sources below — links open the abstract or, where marked, the full free article on the U.S. National Library of Medicine (PubMed / PMC).
- Pickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. International Journal of Molecular Sciences, 2018. Free full text Open-access review mapping GHK-Cu effects on wound healing, gene expression, and tissue regeneration.
- Maquart FX, et al. Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex GHK-Cu. FEBS Letters, 1988. Foundational study showing GHK-Cu stimulates collagen synthesis in fibroblast cultures.
- Seiwerth S, et al. Stable gastric pentadecapeptide BPC 157 and wound healing. Frontiers in Pharmacology, 2021. Free full text Open-access review of BPC 157 across skin wounds, burns, and rodent healing models.
- Chang CH, et al. The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. Journal of Applied Physiology, 2011. In vitro study showing increased tendon fibroblast outgrowth, survival, and migration.
- Xing Y, et al. Progress on the Function and Application of Thymosin β4. Frontiers in Endocrinology, 2021. Free full text Open-access review of Tβ4's roles in actin regulation, angiogenesis, and tissue regeneration.
- Malinda KM, et al. Thymosin beta4 accelerates wound healing. Journal of Investigative Dermatology, 1999. Rat full-thickness wound model; faster re-epithelialization vs. controls.